Clinical Trial Update: Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection [NA]

View source ↗

Summary

This document reports a clinical trial update evaluating the best timing for administering plerixafor during autologous hematopoietic stem cell collection in pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Mozobil (plerixafor)

Snippet

Sponsor: Shi, Patricia, M.D. | Conditions: Multiple Myeloma, Non-Hodgkins Lymphoma | NA | Status: UNKNOWN